Skip to main content
. 2011 Dec 14;17(46):5097–5104. doi: 10.3748/wjg.v17.i46.5097

Table 3.

Leptin and ghrelin concentrations at baseline and end of follow-up in patients infected with hepatitis C virus genotypes-1 and -3 by response to therapy, as well as mixed effect model derived estimates of differences in mean scores (mean ± SD)

Variable Responders Non-responders P-value for the adjusted difference1
Leptin
Baseline (ng/mL) 30.99 (9.185) 38.43 (11.58) NS
End of Follow-up (ng/mL) 23.76 (8.055) 34.10 (11.53) 0.01
Ghrelin
Baseline (ng/mL) 0.532 (0.410) 0.377 (0.223) 0.01
End of Follow-up (ng/mL) 0.438 (0.288) 0.345 (0.237) 0.05
1

Adjusted for both leptin and ghrelin concentrations. NS: Non-significant.